APOE and Atrophy: Conversely, global cerebral atrophy in AD patients with a mean age of 70 years was reduced in an APOE4 allele frequency-dependent manner [79], whereas in older patients, with a mean age of 80 years, atrophy was not different by genotype [78, 80].